Ibere Pharmaceuticals Cl A (IBER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IBER | HRTX | GALT | ||
| Company | Ibere Pharmaceuticals Cl A | Heron Therapeutics | Galectin Therapeutic | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 10.18 | 1.1400 | 2.70 | ||
| High | 10.18 | 1.2050 | 2.78 | ||
| Low | 10.18 | 1.1100 | 2.68 | ||
| Last | 10.18 | 1.1900 | 2.76 | ||
| Change | -0.03 | +0.0200 | +0.07 | ||
| % Change | -0.29% | +1.71% | +2.42% | ||
| Volume | 44,400 | 2,135,143 | 107,657 | ||
| 20-Day Average Volume | 61,365 | 2,039,727 | 153,238 | ||
| Previous Close | 10.21 | 1.1700 | 2.69 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 10.17 | 1.6210 | 2.68 | ||
| 20-Day Raw Stochastic | 5.79% | 15.71% | 42.36% | ||
| 20-Day Relative Strength | 62.60% | 29.89% | 52.67% | ||
| Weighted Alpha | +5.10 | -23.68 | +2.78 | ||
| Today's Opinion | 100% Buy | 100% Sell | 72% Buy | ||
| Previous Opinion | 100% Buy | 100% Sell | 64% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 48% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.10% since 02/17/23 | -7.03% since 11/12/24 | -6.93% since 11/12/24 | ||
| Low | 10.17 on 02/21/23 | 1.1100 on 11/19/24 | 2.65 on 11/18/24 | ||
| High | 10.21 on 02/28/23 | 1.3600 on 11/13/24 | 3.04 on 11/13/24 | ||
| 1-Month | |||||
| %Chg | +0.20% since 02/01/23 | -32.39% since 10/18/24 | +3.18% since 10/18/24 | ||
| Low | 10.15 on 02/06/23 | 1.0400 on 11/12/24 | 2.45 on 11/01/24 | ||
| High | 10.75 on 02/06/23 | 1.9950 on 10/28/24 | 3.17 on 11/11/24 | ||
| 3-Month | |||||
| %Chg | +1.50% since 11/30/22 | -39.90% since 08/19/24 | +17.23% since 08/19/24 | ||
| Low | 10.03 on 12/02/22 | 1.0400 on 11/12/24 | 2.25 on 08/23/24 | ||
| High | 10.75 on 02/06/23 | 2.1500 on 10/04/24 | 3.17 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +3.25% since 09/01/22 | -62.81% since 05/17/24 | -14.71% since 05/17/24 | ||
| Low | 9.87 on 09/02/22 | 1.0400 on 11/12/24 | 1.98 on 08/12/24 | ||
| High | 10.75 on 02/06/23 | 3.9300 on 06/12/24 | 3.28 on 05/21/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 175,605 | 177,951 | 168,830 | ||
| Shares Outstanding, K | 17,250 | 152,095 | 62,762 | ||
| Annual Sales | 0 | 127,040,000 | 0 | ||
| Annual Net Income | 1,560,000 | -110,560,000 | -41,070,000 | ||
| Last Quarter Sales | 0 | 32,810,000 | 0 | ||
| Last Quarter Net Income | 789,819 | -4,850,000 | -11,220,000 | ||
| 60-Month Beta | 0.00 | 1.81 | 0.62 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.06 on 11/14/22 | -0.03 on 11/12/24 | -0.18 on 11/14/24 | ||
| Latest Earnings Date | 03/06/23 | 11/12/24 | 11/18/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||